Robert Wasserman's Stock Ratings

Benchmark Analyst

Robert Wasserman is an analyst at Benchmark. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 11/21/2024

Overall Average Return

2.62%

Smart Score

57.4%

Overall Average Return Percentile

41st

Number of Ratings

113
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

A Closer Look at 7 Analyst Recommendations For Ligand Pharmaceuticals
Unveiling 12 Analyst Insights On Halozyme Therapeutics
Analyst Scoreboard: 8 Ratings For Integer Holdings
What 8 Analyst Ratings Have To Say About Integer Holdings
Critical Insights From Ligand Pharmaceuticals Analyst Ratings: What You Need To Know
Assessing Ligand Pharmaceuticals: Insights From 7 Financial Analysts
A Glimpse Into The Expert Outlook On Halozyme Therapeutics Through 12 Analysts
The Latest Analyst Ratings For Ligand Pharmaceuticals
Navigating 6 Analyst Ratings For Integer Holdings
Critical Insights From Halozyme Therapeutics Analyst Ratings: What You Need To Know
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved